Search database
LIST OPTIONS
Filter
11
Filtered Results: 11
Text search: Schäferhoff, M.
Featured
Language
Document type
Studies & Reports
9
No document type
2
Countries / Regions
Nigeria
1
Mozambique
1
Global
1
Japan
1
Authors & Publishers
BMJ Global Health
2
The Lancet
2
Yamey G.
2
A. Gheorghe
1
Almeida C
1
BJOG An International Journal of Obstetics and Gynaecology
1
Dahab M.
1
Dolan CB, Saunders M, BenYishay A
1
F1000 Research
1
Fewer S.
1
Gelband, Hellen
1
Globalization and Health
1
Grollman C.
1
H. Sakamoto
1
Horton, Susan, et al.
1
Jamison, Dean T.
1
K. Hauck
1
Kraus J.
1
Kraus J. et al.
1
Li Z., Richter L., Lu C.
1
M. K. Sugai et al.
1
Martinez-Alvarez M. et al
1
Nomura, S.
1
Patel P.
1
Pepe VLE
1
Pitt C.
1
PLOS Med
1
PLOS One
1
Quirk, E.J.
1
Sachy, M
1
Schäferhoff M.
1
Schäferhoff M. et al.
1
Schäferhoff, M.
1
Schrade, C.
1
Tanabe M. et al.
1
World Bank
1
Publication Years
Category
Drugs & Medical Equipment
1
Disease Prevention & Control
1
Toolboxes
General Information & Methodology
7
General Information & Methodology
1
Health Financing Toolbox
1
As the culminating volume in the DCP3 series, volume 9 will provide an overview of DCP3 findings and methods, a summary of messages and substantive lessons to be taken from DCP3, and a further discussion of cross-cutting and synthesizing topics across the first eight volumes. The introductory chapte... more
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ... more
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting... more
With sustained economic growth in many parts of the developing world, an increasing number of countries are transitioning away from the most subsidized development finance as they exceed income and other qualification requirements. Cross-country evidence suggests that Development Assistance Committe... more
Marco Schäferhoff and colleagues critique funding estimates for the maternal and child health Millennium Development Goals, and make recommendations for improving the tracking of financing flows and estimating the costs of scaling up interventions for mothers and children.
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health (RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and the Organisation for Economic Co-operation and Development (OECD) policy marker. We... more
Little is known about the patterns of development assistance (DA) for each component of reproductive, maternal, newborn, child and adolescent health (RMNCAH) in conflict-affected countries nor about the DA allocation in relation to the burden of disease
: Development assistance for health (DAH) is one of the most important means for Japan to promote diplomacy with developing countries and contribute to the international community. This study, for the first time, estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and clarified its... more
To provide information on trends on official development assistance (ODA) disbursement patterns for reproductive health activities in 18 conflict-affected countries
Health systems strengthening (HSS) and health security are two pillars of universal health coverage (UHC). Investments in these areas are essential for meeting the Sustainable Development Goals and are of heightened relevance given the emergence of the 2019 novel coronavirus disease (COVID-19). This... more